SLS 10-Q: SEC filing
SELLAS Life Sciences Group
Filed with the SEC on · accession 0001390478-26-000020
SLS filed a 10-Q (quarterly report) with the SEC on Nov 12, 2026. The quarterly report: unaudited results for the quarter plus management’s comments.
Summary of the filing
SELLAS Life Sciences Group filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting 203,859,151 shares of common stock outstanding.
Key details
✦ Ask GOAX AI about this filing — what it means for SLS, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for SLS?
Click hereFrequently asked questions
What did SLS file with the SEC on Nov 12, 2026?
SLS filed a 10-Q (SEC filing). SELLAS Life Sciences Group filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting 203,859,151 shares of common stock outstanding.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
Other SLS SEC filings
- SCHEDULE 13G · SEC filingNov 10, 2026
- SCHEDULE 13G/A · SEC filingOct 27, 2026
- 10-Q · SEC filingAug 11, 2026
- 8-K · SEC filingAug 11, 2026
- 8-K · SEC filingJul 27, 2026
- 8-K · SEC filingJun 25, 2026
- 8-K · SEC filingJun 18, 2026
- 8-K · SEC filingJun 2, 2026
- 10-Q · SEC filingMay 12, 2026
- 8-K · SEC filingMay 12, 2026
Get alerts when SLS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days